🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Walvax Biotechnology Co., Ltd. (SHE:300142)
China flag China · Delayed Price · Currency is CNY
10.00
-0.64 (-6.02%)
Nov 20, 2026, 3:04 PM CST

Walvax Biotechnology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
21.84177.74142.16419.39728.65427.75
Depreciation & Amortization
392.09392.09388.54317.23264.93143.84
Other Amortization
19.6719.6723.0216.110.575.71
Loss (Gain) From Sale of Assets
-0.08-0.081.770.830.38-0.23
Asset Writedown & Restructuring Costs
88.2588.257.6811.311.665.11
Loss (Gain) From Sale of Investments
-32.23-32.2393.31227.64187.54222.86
Provision & Write-off of Bad Debts
148.52148.5264.1439.72-1.28-4.95
Other Operating Activities
371.73-57.6110.72295.46324.44154.22
Change in Accounts Receivable
111.91111.91781.3535.7-1,241-614.65
Change in Inventory
162.93162.93115.88-134.9-178.79-390.03
Change in Accounts Payable
-504.76-504.76-686.19-593.871,075762.2
Operating Cash Flow
764.35490.931,0371,1341,201705.28
Operating Cash Flow Growth
37.27%-52.64%-8.58%-5.64%70.36%517.62%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-376.17-509.54-550.03-945.52-1,091-1,103
Sale of Property, Plant & Equipment
0.560.70.470.740.343.73
Divestitures
---140149.3975.68
Investment in Securities
-228.34188.75-722-10-41.18
Other Investing Activities
303.133.444.96.786.265.74
Investing Cash Flow
-300.81-316.65-1,267-807.99-935.19-977.15

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-144.1-96.51--
Long-Term Debt Issued
-15938.22499.31393.82410
Total Debt Issued
1,472303.138.22595.83393.82410
Short-Term Debt Repaid
---4.6-189.19--
Long-Term Debt Repaid
--407.82-353.68-78.61-405.35-149.73
Lease Payments
-14.12-14.12-24.1-27.51-14.15-9.73
Total Debt Repaid
-295.12-407.82-358.28-267.8-405.35-149.73
Net Debt Issued (Repaid)
1,177-104.72-320.07328.03-11.54260.27
Issuance of Common Stock
2.72.70.1836.18397.111,221
Repurchase of Common Stock
----72.21-286.42-
Common Dividends Paid
-1,035-789.86-40.94-19.98-50.11-83.31
Other Financing Activities
-1,374-1,692-10.21-35.3745.77338.48
Financing Cash Flow
-1,230-2,584-371.03236.6494.821,736

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-8.49-0.955.412.274.07-0.12
Net Cash Flow
-774.55-2,411-595.76564.69365.191,464

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
388.18-18.62486.49188.25110.31-398.21
Free Cash Flow Growth
309.35%-158.43%70.65%--
Free Cash Flow Margin
21.02%-0.77%17.24%4.58%2.17%-11.50%
Free Cash Flow Per Share
0.24-0.010.300.120.07-0.25
Levered Free Cash Flow
1,013-180.28406.8574.57-495.85-257.05
Unlevered Free Cash Flow
1,030-179.71412.1278.29-491.4-253.44
Free Cash Flow After Leases
374.06-32.74462.39160.7596.17-407.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
187.87131.45136.82264.12309.57244.55
Change in Working Capital
-245.43-245.43205.17-193.9-315.4-249.02